Structural Enzymology and Thermodynamics Group, Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 606 WBSB 608, Baltimore, MD 21205, USA.
Structural Enzymology and Thermodynamics Group, Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, 725 North Wolfe Street, 606 WBSB 608, Baltimore, MD 21205, USA; Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross Building 844, Baltimore, MD 21205, USA; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Structure. 2020 Apr 7;28(4):465-474.e5. doi: 10.1016/j.str.2020.01.010. Epub 2020 Feb 10.
Class I phosphoinositide-3-kinases (PI3Ks) phosphorylate PIP at its 3' inositol position to generate PIP, a second messenger that influences signaling cascades regulating cellular growth, survival, and proliferation. Previous studies have suggested that PI3Kα activation involves dislodging the p85α nSH2 domain from the p110α catalytic subunit by binding activated receptor tyrosine kinases. We carried out molecular dynamics simulations to determine, mechanistically and structurally, how PI3Kα conformations are influenced by physiological effectors and the nSH2 domain. We demonstrate that changes in protein dynamics mediated by allosteric regulation significantly increase the population of catalytically competent states without changing the enzyme ground-state structure. Furthermore, we demonstrate that modulation of active-site residue interactions with enzyme substrates can reciprocally influence nSH2 domain dynamics. Together, these results suggest that dynamic allostery plays a role in populating the catalytically competent conformation of PI3Kα, and provide a key platform for the design of novel chemotherapeutic PI3Kα inhibitors.
I 类磷酸肌醇 3-激酶 (PI3Ks) 在其 PIP 的 3' 位的肌醇上磷酸化,生成第二信使,影响调节细胞生长、存活和增殖的信号级联反应。先前的研究表明,PI3Kα 的激活涉及通过与激活的受体酪氨酸激酶结合,将 p85α nSH2 结构域从 p110α 催化亚基上分离。我们进行了分子动力学模拟,以从机制和结构上确定 PI3Kα 构象如何受到生理效应物和 nSH2 结构域的影响。我们证明,通过变构调节介导的蛋白质动力学变化显著增加了催化有效状态的种群,而不会改变酶的基态结构。此外,我们证明了与酶底物的活性位点残基相互作用的调节可以相互影响 nSH2 结构域的动力学。总之,这些结果表明动态变构在填充 PI3Kα 的催化有效构象中起作用,并为设计新型化学治疗 PI3Kα 抑制剂提供了关键平台。